Auxly Cannabis Group Inc. (XLY.TO)
CAD 0.08
(-6.25%)
CAD 0.08
(-6.25%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 210.85 Million CAD | -14.33% |
| 2022 | 246.13 Million CAD | 1.58% |
| 2021 | 242.3 Million CAD | 29.28% |
| 2020 | 187.43 Million CAD | 25.22% |
| 2019 | 149.68 Million CAD | 7.17% |
| 2018 | 139.66 Million CAD | 368.91% |
| 2017 | 29.78 Million CAD | 90273.35% |
| 2016 | 32.95 Thousand CAD | 21.81% |
| 2015 | 27.05 Thousand CAD | -12.81% |
| 2014 | 31.03 Thousand CAD | -48.66% |
| 2013 | 60.44 Thousand CAD | -9.03% |
| 2012 | 66.44 Thousand CAD | -16.99% |
| 2011 | 80.04 Thousand CAD | -9.98% |
| 2010 | 88.91 Thousand CAD | 29.31% |
| 2009 | 68.76 Thousand CAD | 72.18% |
| 2008 | 39.93 Thousand CAD | 27.85% |
| 2007 | 31.23 Thousand CAD | -99.97% |
| 2006 | 115.01 Million CAD | -12.5% |
| 2005 | 131.45 Million CAD | 40.15% |
| 2004 | 93.79 Million CAD | 74.3% |
| 2003 | 53.81 Million CAD | 13.64% |
| 2002 | 47.35 Million CAD | 4.74% |
| 2001 | 45.2 Million CAD | -12.24% |
| 2000 | 51.51 Million CAD | 5.93% |
| 1999 | 48.63 Million CAD | 86.81% |
| 1998 | 26.03 Million CAD | 29.06% |
| 1997 | 20.17 Million CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 154.31 Million CAD | -1.11% |
| 2024 Q1 | 156.04 Million CAD | -25.99% |
| 2023 Q3 | 205.48 Million CAD | -17.74% |
| 2023 FY | 210.85 Million CAD | -14.33% |
| 2023 Q2 | 249.8 Million CAD | -1.46% |
| 2023 Q4 | 210.85 Million CAD | 2.61% |
| 2023 Q1 | 253.49 Million CAD | 2.99% |
| 2022 Q3 | 243.95 Million CAD | -1.47% |
| 2022 Q4 | 246.13 Million CAD | 0.89% |
| 2022 FY | 246.13 Million CAD | 1.58% |
| 2022 Q2 | 247.59 Million CAD | 1.55% |
| 2022 Q1 | 243.8 Million CAD | 0.62% |
| 2021 Q1 | 184.99 Million CAD | -1.3% |
| 2021 FY | 242.3 Million CAD | 29.28% |
| 2021 Q4 | 242.3 Million CAD | 46.44% |
| 2021 Q3 | 165.47 Million CAD | 7.78% |
| 2021 Q2 | 153.52 Million CAD | -17.01% |
| 2020 Q1 | 144 Million CAD | -3.8% |
| 2020 Q4 | 187.43 Million CAD | 5.74% |
| 2020 Q2 | 156.57 Million CAD | 8.73% |
| 2020 Q3 | 177.25 Million CAD | 13.21% |
| 2020 FY | 187.43 Million CAD | 25.22% |
| 2019 FY | 149.68 Million CAD | 7.17% |
| 2019 Q2 | 142.02 Million CAD | 3.79% |
| 2019 Q3 | 262.12 Million CAD | 84.57% |
| 2019 Q1 | 136.83 Million CAD | -2.03% |
| 2019 Q4 | 149.68 Million CAD | -42.9% |
| 2018 Q1 | 99.49 Million CAD | 234.03% |
| 2018 Q3 | 133.21 Million CAD | 10.06% |
| 2018 FY | 139.66 Million CAD | 368.91% |
| 2018 Q4 | 139.66 Million CAD | 4.84% |
| 2018 Q2 | 121.03 Million CAD | 21.65% |
| 2017 Q4 | 29.78 Million CAD | 12.06% |
| 2017 FY | 29.78 Million CAD | 90273.35% |
| 2017 Q3 | 26.57 Million CAD | 5.46% |
| 2017 Q2 | 25.2 Million CAD | 2801.07% |
| 2017 Q1 | 868.75 Thousand CAD | 2535.93% |
| 2016 Q2 | 15.95 Thousand CAD | -0.94% |
| 2016 Q1 | 16.1 Thousand CAD | -40.49% |
| 2016 Q4 | 32.95 Thousand CAD | 12.76% |
| 2016 FY | 32.95 Thousand CAD | 21.81% |
| 2016 Q3 | 29.22 Thousand CAD | 83.25% |
| 2015 Q3 | 20.66 Thousand CAD | -12.78% |
| 2015 Q1 | 35.04 Thousand CAD | 12.91% |
| 2015 FY | 27.05 Thousand CAD | -12.81% |
| 2015 Q2 | 23.68 Thousand CAD | -32.4% |
| 2015 Q4 | 27.05 Thousand CAD | 30.96% |
| 2014 FY | 31.03 Thousand CAD | -48.66% |
| 2014 Q4 | 31.03 Thousand CAD | -23.42% |
| 2014 Q2 | 26.82 Thousand CAD | -46.29% |
| 2014 Q3 | 40.52 Thousand CAD | 51.05% |
| 2014 Q1 | 49.94 Thousand CAD | -17.37% |
| 2013 Q4 | 60.44 Thousand CAD | -0.93% |
| 2013 FY | 60.44 Thousand CAD | -9.03% |
| 2013 Q3 | 61.01 Thousand CAD | 71.0% |
| 2013 Q2 | 35.68 Thousand CAD | -39.41% |
| 2013 Q1 | 58.89 Thousand CAD | -11.37% |
| 2012 Q4 | 66.44 Thousand CAD | 34.58% |
| 2012 Q1 | 87.95 Thousand CAD | 9.88% |
| 2012 Q2 | 46.89 Thousand CAD | -46.68% |
| 2012 FY | 66.44 Thousand CAD | -16.99% |
| 2012 Q3 | 49.37 Thousand CAD | 5.29% |
| 2011 Q2 | 61.23 Thousand CAD | -9.28% |
| 2011 Q3 | 65.9 Thousand CAD | 7.64% |
| 2011 Q4 | 80.04 Thousand CAD | 21.45% |
| 2011 FY | 80.04 Thousand CAD | -9.98% |
| 2011 Q1 | 67.49 Thousand CAD | -24.09% |
| 2010 Q1 | 59.11 Thousand CAD | -14.03% |
| 2010 Q2 | 55.24 Thousand CAD | -6.55% |
| 2010 Q3 | 78.59 Thousand CAD | 42.28% |
| 2010 Q4 | 88.91 Thousand CAD | 13.13% |
| 2010 FY | 88.91 Thousand CAD | 29.31% |
| 2009 FY | 68.76 Thousand CAD | 72.18% |
| 2009 Q2 | 19.73 Thousand CAD | -57.66% |
| 2009 Q1 | 46.6 Thousand CAD | 16.7% |
| 2009 Q4 | 68.76 Thousand CAD | 102.89% |
| 2009 Q3 | 33.89 Thousand CAD | 71.75% |
| 2008 FY | 39.93 Thousand CAD | 27.85% |
| 2008 Q1 | 30.93 Thousand CAD | -0.97% |
| 2008 Q2 | 600.00 CAD | -98.06% |
| 2008 Q3 | 16.29 Thousand CAD | 2615.33% |
| 2008 Q4 | 39.93 Thousand CAD | 145.13% |
| 2007 Q2 | 103.95 Million CAD | -9.9% |
| 2007 Q1 | 115.37 Million CAD | 0.31% |
| 2007 Q4 | 31.23 Thousand CAD | -99.96% |
| 2007 Q3 | 82.91 Million CAD | -20.24% |
| 2007 FY | 31.23 Thousand CAD | -99.97% |
| 2006 Q3 | 123.55 Million CAD | -10.19% |
| 2006 Q4 | 115.01 Million CAD | -6.91% |
| 2006 Q2 | 137.57 Million CAD | 2.09% |
| 2006 Q1 | 134.76 Million CAD | 2.52% |
| 2006 FY | 115.01 Million CAD | -12.5% |
| 2005 Q3 | 104.79 Million CAD | 0.89% |
| 2005 Q1 | 99.55 Million CAD | 6.14% |
| 2005 Q4 | 131.45 Million CAD | 25.44% |
| 2005 FY | 131.45 Million CAD | 40.15% |
| 2005 Q2 | 103.87 Million CAD | 4.34% |
| 2004 Q2 | 68.64 Million CAD | 15.29% |
| 2004 Q3 | 71.83 Million CAD | 4.65% |
| 2004 Q4 | 93.79 Million CAD | 30.56% |
| 2004 FY | 93.79 Million CAD | 74.3% |
| 2004 Q1 | 59.54 Million CAD | 10.66% |
| 2003 FY | 53.81 Million CAD | 13.64% |
| 2003 Q4 | 53.81 Million CAD | 8.42% |
| 2003 Q2 | 48.46 Million CAD | 1.09% |
| 2003 Q3 | 49.63 Million CAD | 2.4% |
| 2003 Q1 | 47.94 Million CAD | 1.26% |
| 2002 Q2 | 46.27 Million CAD | 3.1% |
| 2002 FY | 47.35 Million CAD | 4.74% |
| 2002 Q4 | 47.35 Million CAD | 1.23% |
| 2002 Q3 | 46.77 Million CAD | 1.09% |
| 2002 Q1 | 44.88 Million CAD | -0.72% |
| 2001 Q2 | 43.8 Million CAD | -14.76% |
| 2001 Q1 | 51.38 Million CAD | -0.25% |
| 2001 Q3 | 43.94 Million CAD | 0.33% |
| 2001 FY | 45.2 Million CAD | -12.24% |
| 2001 Q4 | 45.2 Million CAD | 2.88% |
| 2000 Q3 | 48.14 Million CAD | -2.34% |
| 2000 FY | 51.51 Million CAD | 5.93% |
| 2000 Q1 | 48.91 Million CAD | 0.58% |
| 2000 Q4 | 51.51 Million CAD | 7.0% |
| 2000 Q2 | 49.29 Million CAD | 0.78% |
| 1999 Q3 | 44.37 Million CAD | 56.64% |
| 1999 Q2 | 28.32 Million CAD | -0.95% |
| 1999 Q4 | 48.63 Million CAD | 9.6% |
| 1999 FY | 48.63 Million CAD | 86.81% |
| 1999 Q1 | 28.59 Million CAD | 0.0% |
| 1998 FY | 26.03 Million CAD | 29.06% |
| 1998 Q2 | 25.85 Million CAD | -1.09% |
| 1998 Q1 | 26.14 Million CAD | 25.07% |
| 1997 Q4 | 20.9 Million CAD | 0.0% |
| 1997 FY | 20.17 Million CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aurora Cannabis Inc. | 236.8 Million CAD | 10.957% |
| Avicanna Inc. | 13.99 Million CAD | -1406.229% |
| Avant Brands Inc. | 33.22 Million CAD | -534.653% |
| Cardiol Therapeutics Inc. | 8.45 Million CAD | -2394.168% |
| Crescita Therapeutics Inc. | 5.77 Million CAD | -3550.571% |
| Knight Therapeutics Inc. | 198.62 Million CAD | -6.16% |
| MediPharm Labs Corp. | 10.93 Million CAD | -1828.805% |
| OrganiGram Holdings Inc. | 26.83 Million CAD | -685.842% |
| Canopy Growth Corporation | 799.82 Million CAD | 73.637% |
| Willow Biosciences Inc. | 3.23 Million CAD | -6413.964% |